PROCEPT BioRobotics (PRCT) Free Cash Flow Growth (1y) (2021 - 2026)
PROCEPT BioRobotics (PRCT) Free Cash Flow Growth (1y) (2021 - 2026) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | FCF Growth (1y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 183.64 Bn | 176.34 Bn | 6.27 Bn | -1.82% |
| 2 | Stryker | 129.04 Bn | 126.16 Bn | 3.81 Bn | 226.77% |
| 3 | Medtronic | 109.04 Bn | 99.82 Bn | 6.41 Bn | 0.77% |
| 4 | Boston Scientific | 68.54 Bn | 67.08 Bn | 3.61 Bn | -51.69% |
| 5 | Edwards Lifesciences | 48.67 Bn | 45.00 Bn | 1.29 Bn | -109.40% |
| 6 | Dexcom | 28.40 Bn | 27.28 Bn | 750.30 Mn | 363.84% |
| 7 | GE HealthCare Technologies | 28.37 Bn | 26.08 Bn | 1.98 Bn | -31.71% |
| 8 | Smith & Nephew | 26.92 Bn | 26.34 Bn | - | - |
| 9 | Koninklijke Philips | 25.48 Bn | 22.36 Bn | 2.07 Bn | 133.09% |
| 10 | PROCEPT BioRobotics | 1.03 Bn | 779.47 Mn | 53.95 Mn | -123.44% |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -123.44% |
| Dec 31, 2025 | 62.78% |
| Sep 30, 2025 | 39.99% |
| Jun 30, 2025 | -0.70% |
| Mar 31, 2025 | 44.08% |
| Dec 31, 2024 | -221.83% |
| Sep 30, 2024 | 35.95% |
| Jun 30, 2024 | 46.11% |
| Mar 31, 2024 | 20.41% |
| Dec 31, 2023 | 62.26% |
| Sep 30, 2023 | -15.72% |
| Jun 30, 2023 | -97.74% |
| Mar 31, 2023 | -122.08% |
| Dec 31, 2022 | -59.66% |
| Sep 30, 2022 | -67.90% |
| Jun 30, 2022 | -30.18% |
| Mar 31, 2022 | -21.95% |
| Dec 31, 2021 | -25.15% |